RPS6KA1 and nasopharyngeal carcinoma: In this study, we explored the antitumor effects of ZLMP1-C affibody molecules on EBV-positive NPC cell lines, and further elucidate the inhibitory effects of ZLMP1-C277 on MEK/ERK/p90RSK signaling pathway in NPC cells.